Načítá se...

Overcoming Linsitinib intrinsic resistance through inhibition of nuclear factor‐κB signaling in esophageal squamous cell carcinoma

The aim of this study is to evaluate the efficacy of insulin‐like growth factor 1 receptor (IGF‐1R) inhibitor Linsitinib, in esophageal squamous cell carcinoma (ESCC), and to characterize special biomarker to screen Linsitinib‐sensitive patients as well as explore the molecular‐resistant mechanism t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Wu, Junzhou, Chen, Kaiyan, Zhang, Fanrong, Jin, Jiaoyue, Zhang, Nan, Li, Dan, Ying, Lisha, Chen, Wei, Yu, Herbert, Mao, Weimin, Su, Dan
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5463077/
https://ncbi.nlm.nih.gov/pubmed/28440057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1068
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!